GLP-1 medications represent one of the fastest-growing drug expenditure categories, and insurers are struggling to absorb the spending
More studies are needed, though, to confirm the aforementioned taste-altering findings and determine how common taste changes and dysgeusia may be
This matters most in groups already vulnerable to changes in bone density, including: Post-menopausal women Adults over 50 Individuals with low resistance training exposure Athletes experiencing chronically low energy availability GLP-1 therapy is not contraindicated for these groups
Alternatively, a hydroxyapatite toothpaste like Boka or RiseWell provides remineralization support without requiring fluoride, though fluoride remains the most evidence-backed option for cavity prevention
Further studies to determine the accuracy of GUS in the setting of GLP-1 RAs would be beneficial to set guidelines for the preoperative use of GUS in the setting of GLP-1 RA, as well as clarifying uncertainty within these guidelines among these patients
At BodyLogicMD, our providers focus on personalized care, educating you on potential benefits, side effects, and strategies to support lean mass, strength, and long-term results
